esVolta, LP Secures $

Nexo

Nexo is a premier digital assets wealth platform designed to empower clients to grow, manage, and preserve their crypto holdings. Our mission is to lead the next generation of wealth creation by focusing on customer success and delivering tailored solutions that build enduring value, supported by 24/7 client care. Since 2018, Nexo has provided unmatched opportunities to forward-thinking clients in over 199+ jurisdictions. With $7+ billion in AUM and $430+ billion processed, we bring lasting value to millions worldwide. Our all-in-one platform combines advanced technology with a client-first approach, offering high-yield flexible and fixed-term savings, crypto-backed loans, sophisticated trading tools, and liquidity solutions, including the first crypto debit/credit card. Built on deep industry expertise, a sustainable business model, robust infrastructure, stringent security, and global licensing, Nexo champions innovation and long-lasting prosperity. Posts are not intended for U.S. or U.K. users. U.S. users, please refer to Nexo USA's LinkedIn page: https://www.linkedin.com/company/nexo-usa/ U.K. users, please refer to Nexo UK's LinkedIn page: https://www.linkedin.com/company/nexouk

Fund Street Technologies

Fund Street Technologies is the nation's leading Technology Driven Small Business Financing Platform. Fund Street Technologies combines the team’s experience in technology, finance, and direct marketing to build the best SMB Platform in the United States. Over the past 10 years we have facilitated funding for thousands of business owners across the country. Our Mission is to combine our expertise & technology to help small business owners responsibly & rapidly acquire working capital for growth.

TurnUp Activism

TurnUp is a 501(c)(3) non-profit mobile app and organization that has embarked on a mission to build the most organized, active, competent, educated and powerful progressive grassroots activist network of young people. In 2020, as the largest and fastest-growing youth voter turnout and activism organization and mobile app, TurnUp reached 36 million young voters nationally with voter registration and election information; texted 1 million young Georgians; reached each young Georgian on social media 8x in the 6 weeks before the runoff; made 17,000 connections between young activists through the TurnUp mobile app; and trained 1,600 young activists who completed over 2,000 volunteer shifts in a 3 months long program. Youth turnout increased more than 10 points. TurnUp consistently creates and invests in new civic technologies and ideas including an innovative mobile app for youth activism and the organization includes staff as well as 300 youth organizers working on a daily basis and over 20,000 young people that are mobilized to get out the vote and stop voter suppression. Download TurnUp in the app store now! turnupactivism.page.link/download Connect & follow! Instagram - https://www.instagram.com/turnupactivism/ TikTok - https://www.tiktok.com/@turnupactivism?lang=en Twitter - https://twitter.com/turnupactivism Facebook -https://www.facebook.com/turnupactivism/

Neion Bio

At Neion Bio, we use breakthroughs in genetic engineering and stem cell biology to reinvent the entire manufacturing process for biopharmaceuticals. Our platform manufactures virtually any complex molecule with orders of magnitude superior cost, scalability, and resiliency. Biomanufacturing reinvented. Medicine, democratized.

ChAbS (Chinese Antibody Society)

The ChAbS(华人抗体协会) is an independent non-profit, non-government global professional organization with focus upon antibody-based therapeutics. The mission of the society is to bring together industry, academics, healthcare providers, and investors to connect, communicate, and collaborate on the discovery, development, manufacturing, and marketing of therapeutic antibodies. Through its programs and services, the society serves as a nurturing platform to foster the productive interaction and networking among its members worldwide. The society, in collaboration with Oxford University Press, publishes its official journal, Antibody Therapeutics which is indexed by ESCI (IF: 4.5), PubMed and Scopus (CiteScore: 8.5).